Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Scios and DuPont Merck collaborate on Alzheimer's disease research

Nov. 26, 1997

Extended-release Effexor introduced in U.S. for depression

Nov. 26, 1997

Nefadar: new antidepressant introduced in Germany

Nov. 26, 1997

Neuroprotective efficacy of lamotrigine in rat cardiac arrest model

Nov. 25, 1997

CP-101606 evaluated in cat model of occlusive stroke

Nov. 25, 1997

German launch for Eisai/Pfizer Alzheimer's Rx

Nov. 25, 1997

Synthelabo's Solian introduced in U.K.

Nov. 25, 1997

New valproic acid analogue selected as candidate anticonvulsant

Nov. 25, 1997

Sankyo discloses inositol 1,4,5-triphosphate inhibitors

Nov. 25, 1997

SKB describes novel 5-HT1B antagonists

Nov. 25, 1997

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 10, 2025
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...
Magnet, Eli Lilly sign $1.25B molecular glue deal for oncology
BioWorld
About 17 months after emerging from stealth with its Trueglue discovery platform, Magnet Biomedicine Inc. has joined with Eli Lilly and Co. to discover, develop...